ANI Pharmaceuticals Inc (USD)
ANIP
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range60.27 | 61.56
52-Wk Range36.92 | 86.96
Last Close61.29
Mkt Cap (m)741.06
Dividend yield-
ISINUS00182C1036
Volume63,499
Exchange VenueNAS

Company Profile

ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary is engaged in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals.

Key Information
Price/Earning45.74
Price/Book3.48
Price/Sales3.41
P/CF10.80
Rev Growth (3 year avg)38.23
EPS Growth (3 year avg)-0.01
Operating Margin % 17.54
Net Margin %7.69
Return on Equity8.25
Debt/Equity0.93

Legal Documents

Prospectus
en 08/12/2014
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)305676129177202
Operating Income (m)12033272935
Net Income (m)29154-115
Basic EPS-0.922.611.340.34-0.091.31
Avg. Diluted Shares Outstanding (m)51112121212
Balance Sheet
USD201320142015201620172018
Current Assets (m)28203193103132153
Non Current Assets (m)176093220281278
Total Assets (m)45264285323412431
Current Liabilities (m)413123239166
Total Liabilities (m)------
Total Equity (m)41140160170175197
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-52217273967
Capital Expenditure (m)-36-33-149-108-11
Figures are quoted in USD unless stated otherwise
-0.80 (-1.31%)
$
60.49
Last Price